EO14398 - broad agency announcement (BAA) FY26C1IP1 valid approaches to integrating patient science into medical device studies

Active Definitive Contract Awarded Last action

Contract number
75F40126C00081
Awardee
Awarding agency
Obligated
$749,762

Award facts

Contract value 100% obligated
$749,762.00 Current and potential, with all options
Completion date 1% complete
Current and potential, with all options
Contracting staff
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Basic Research
Pricing
Firm Fixed Price
Place of performance
Durham, NC 27705, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Food and Drug Administration awarded a $749,762 definitive contract to Duke University for valid approaches to integrating patient science into medical device studies under BAA FY26C1IP1 on September 30, 2026.

Performance runs through September 29, 2029 at Durham, North Carolina. The contract is firm fixed price with no set-aside applied.

Quick answers

Who was awarded contract 75F40126C00081?

75F40126C00081 was awarded to Duke University by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.

How much is contract 75F40126C00081 worth?

The government has obligated $749,762 on 75F40126C00081.

Was contract 75F40126C00081 competed?

The extent of competition for 75F40126C00081 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award